Ribavirin and IFN-&alpha; combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 41

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

251

HTML

1440

Figures (1-2)

223

Tables (1-2)

199

Sum=2113

Nov 7, 2007 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Nov 7, 2007; 13(41): 5440-5445
Published online Nov 7, 2007. doi: 10.3748/wjg.v13.i41.5440

Full Size Figure Download Figure

Figure 1 Abrogation of antigen-specific T-cell proliferative responses from patients 1-4 at 12 mo (^bP < 0. 01 vs T cell and Anti CD8+).

Citation: Ren FY, Jin H, Piao XX, Piao FS. Ribavirin and IFN-α combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B. World J Gastroenterol 2007; 13(41): 5440-5445
URL: https://www.wjgnet.com/1007-9327/full/v13/i41/5440.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i41.5440